MedPath

Gastric Emptying After Sleeve Gastrectomy

Recruiting
Conditions
Bariatric Surgery
Gastric Emptying
Interventions
Other: MRI and scintigraphy
Registration Number
NCT06407193
Lead Sponsor
Rijnstate Hospital
Brief Summary

Sleeve gastrectomy (SG) increases gastrointestinal motility, which influences feelings of fullness and satiety. By understanding the differences in gastric emptying (GE) between patients with sufficient weight loss (Total weight loss \[TWL\] \> 35%) and insufficient weight loss (TWL \< 25%), better insight in the aetiology of weight loss after sleeve gastrectomy may be obtained. GE will be measured with scintigraphy and MRI.

Detailed Description

Sleeve gastrectomy (SG) increases gastrointestinal motility, which influences feelings of fullness and satiety. Patients' weight loss response on SG varies widely and is difficult to predict. By understanding the differences in gastric emptying (GE) between patients with sufficient weight loss (Total weight loss \[TWL\] \> 35%) and insufficient weight loss (TWL \< 25%), better insight in the aetiology of weight loss after sleeve gastrectomy may be obtained. GE will be measured with scintigraphy and MRI. MRI is a non-invasive imaging method which provides more detailed images of the SG compared to the conventionally used scintigraphy scans.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
6
Inclusion Criteria
  • Women aged between 20 and 55 years who underwent sleeve gastrectomy as primary procedure with either TWL < 25% or TWL > 35%.
  • Patients who had a follow-up period of 2-3 years after sleeve gastrectomy
Exclusion Criteria
  • Maximum BMI >50 kg/m2
  • Patients with a disease known to affect appetite, gastric emptying or gastrointestinal motility
  • Patients who are unable to stop medications that affect gastric emptying and/or motility prior to measurements. It is depending on t1/2 for how long they need to stop medication
  • Patients who started menopause
  • Patients with gastrointestinal problems or, gastric or intestinal diseases
  • Patients with a drug or alcohol addiction
  • Patients who are unable to stop smoking for 24h
  • Patients who are pregnant or lactating
  • Patients who have an intolerance or allergy for one of the components of the test product
  • Patients who have a contra-indication to MRI scanning

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Successful weight loss groupMRI and scintigraphyWomen aged between 20 and 55 years who underwent sleeve gastrectomy as primary procedure with TWL \> 35%
Poor weight loss groupMRI and scintigraphyWomen aged between 20 and 55 years who underwent sleeve gastrectomy as primary procedure with TWL \< 25%
Primary Outcome Measures
NameTimeMethod
Gastric emptying compared between patients with poor and successful weight loss2-3 years

Gastric emptying (T1/2 \[min\] and retention \[%/min\])

Gastric emptying compared between measured with MRI and scintigraphy2-3 years

Gastric emptying (T1/2 \[min\] and retention \[%/min\])

Secondary Outcome Measures
NameTimeMethod
to compare subjective ratings of gastric fullness and wellbeing between patients with successful and unsuccessful weight loss2-3 years

questionnaires (VAS-scale, MAIA, HADS, EBBS, Power of food scale, and Food tolerance test)

to assess the association between gastric emptying rate and gastric sleeve characteristics in each group2-3 years

association between outcome 1, 2 and 3

Sleeve characteristics compared between patients with successful and unsuccessful (poor) weight loss2-3 years

Volume (sleeve size \[mL\] and gastric acid \[mL\])

Trial Locations

Locations (1)

Rijnstate Hospital

🇳🇱

Arnhem, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath